| Dr Michael W Jung, MD | |
|
15 Hospital Dr, York, ME 03909-1011 | |
| (207) 363-4321 | |
| (207) 363-0120 |
| Full Name | Dr Michael W Jung |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 15 Hospital Dr, York, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659452522 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 018034 (Maine) | Primary |
| Entity Name | Bridgton Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154370153 PECOS PAC ID: 8123919099 Enrollment ID: O20040322000534 |
News Archive
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
Preventive vaccination against infectious diseases has been a major milestone for the health of modern society. The development of therapeutic vaccination against established diseases is much more difficult. For more than 100 years researchers have already tried to develop cancer vaccines and now first promising clinical results raise hopes. A summary of the most attractive new approaches gave Professor Carmen Scheibenbogen, Institut für Medizinische Immunologie, Charité-Universitätsmedizin, at a press conference in Berlin.
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
In the wake of news regarding counterfeit Avastin hitting the US market, a new analysis released by LegitScript.com estimates that out of roughly 450 companies with ICANN accreditations to sell domain names, over 71% of all rogue online pharmacies are clustered with just ten Registrars, with over 50% of all rogue online pharmacies at just two Registrars.
New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
› Verified 6 days ago
| Entity Name | Central Maine Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441 |
News Archive
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
Preventive vaccination against infectious diseases has been a major milestone for the health of modern society. The development of therapeutic vaccination against established diseases is much more difficult. For more than 100 years researchers have already tried to develop cancer vaccines and now first promising clinical results raise hopes. A summary of the most attractive new approaches gave Professor Carmen Scheibenbogen, Institut für Medizinische Immunologie, Charité-Universitätsmedizin, at a press conference in Berlin.
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
In the wake of news regarding counterfeit Avastin hitting the US market, a new analysis released by LegitScript.com estimates that out of roughly 450 companies with ICANN accreditations to sell domain names, over 71% of all rogue online pharmacies are clustered with just ten Registrars, with over 50% of all rogue online pharmacies at just two Registrars.
New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
› Verified 6 days ago
| Entity Name | Rumford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205991122 PECOS PAC ID: 3870583511 Enrollment ID: O20040514000890 |
News Archive
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
Preventive vaccination against infectious diseases has been a major milestone for the health of modern society. The development of therapeutic vaccination against established diseases is much more difficult. For more than 100 years researchers have already tried to develop cancer vaccines and now first promising clinical results raise hopes. A summary of the most attractive new approaches gave Professor Carmen Scheibenbogen, Institut für Medizinische Immunologie, Charité-Universitätsmedizin, at a press conference in Berlin.
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
In the wake of news regarding counterfeit Avastin hitting the US market, a new analysis released by LegitScript.com estimates that out of roughly 450 companies with ICANN accreditations to sell domain names, over 71% of all rogue online pharmacies are clustered with just ten Registrars, with over 50% of all rogue online pharmacies at just two Registrars.
New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
› Verified 6 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376528398 PECOS PAC ID: 6406766781 Enrollment ID: O20040812001065 |
News Archive
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
Preventive vaccination against infectious diseases has been a major milestone for the health of modern society. The development of therapeutic vaccination against established diseases is much more difficult. For more than 100 years researchers have already tried to develop cancer vaccines and now first promising clinical results raise hopes. A summary of the most attractive new approaches gave Professor Carmen Scheibenbogen, Institut für Medizinische Immunologie, Charité-Universitätsmedizin, at a press conference in Berlin.
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
In the wake of news regarding counterfeit Avastin hitting the US market, a new analysis released by LegitScript.com estimates that out of roughly 450 companies with ICANN accreditations to sell domain names, over 71% of all rogue online pharmacies are clustered with just ten Registrars, with over 50% of all rogue online pharmacies at just two Registrars.
New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
› Verified 6 days ago
| Entity Name | Penobscot Bay Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982645305 PECOS PAC ID: 2163320508 Enrollment ID: O20060316000020 |
News Archive
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
Preventive vaccination against infectious diseases has been a major milestone for the health of modern society. The development of therapeutic vaccination against established diseases is much more difficult. For more than 100 years researchers have already tried to develop cancer vaccines and now first promising clinical results raise hopes. A summary of the most attractive new approaches gave Professor Carmen Scheibenbogen, Institut für Medizinische Immunologie, Charité-Universitätsmedizin, at a press conference in Berlin.
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
In the wake of news regarding counterfeit Avastin hitting the US market, a new analysis released by LegitScript.com estimates that out of roughly 450 companies with ICANN accreditations to sell domain names, over 71% of all rogue online pharmacies are clustered with just ten Registrars, with over 50% of all rogue online pharmacies at just two Registrars.
New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
› Verified 6 days ago
| Entity Name | Bluewater Emergency Partners Of Brunswick, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043640204 PECOS PAC ID: 3375774227 Enrollment ID: O20140319000012 |
News Archive
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
Preventive vaccination against infectious diseases has been a major milestone for the health of modern society. The development of therapeutic vaccination against established diseases is much more difficult. For more than 100 years researchers have already tried to develop cancer vaccines and now first promising clinical results raise hopes. A summary of the most attractive new approaches gave Professor Carmen Scheibenbogen, Institut für Medizinische Immunologie, Charité-Universitätsmedizin, at a press conference in Berlin.
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
In the wake of news regarding counterfeit Avastin hitting the US market, a new analysis released by LegitScript.com estimates that out of roughly 450 companies with ICANN accreditations to sell domain names, over 71% of all rogue online pharmacies are clustered with just ten Registrars, with over 50% of all rogue online pharmacies at just two Registrars.
New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael W Jung, MD 15 Hospital Dr, York, ME 03909-1011 Ph: (207) 363-4321 | Dr Michael W Jung, MD 15 Hospital Dr, York, ME 03909-1011 Ph: (207) 363-4321 |
News Archive
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
Preventive vaccination against infectious diseases has been a major milestone for the health of modern society. The development of therapeutic vaccination against established diseases is much more difficult. For more than 100 years researchers have already tried to develop cancer vaccines and now first promising clinical results raise hopes. A summary of the most attractive new approaches gave Professor Carmen Scheibenbogen, Institut für Medizinische Immunologie, Charité-Universitätsmedizin, at a press conference in Berlin.
A new analysis indicates that radiocontrast, which is commonly used during selected imaging tests may be less hazardous than previously thought. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, suggest that imaging studies that might help save or improve lives are being unnecessarily withheld from patients owing to exaggerated fears.
In the wake of news regarding counterfeit Avastin hitting the US market, a new analysis released by LegitScript.com estimates that out of roughly 450 companies with ICANN accreditations to sell domain names, over 71% of all rogue online pharmacies are clustered with just ten Registrars, with over 50% of all rogue online pharmacies at just two Registrars.
New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.
› Verified 6 days ago
Mary Samantha Jones, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Loving Kindness Way, York, ME 03909 Phone: 207-363-0390 | |
Dr. Lawrence Anthony Schlemann, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 Hospital Dr, York, ME 03909 Phone: 207-363-4321 Fax: 207-363-0120 | |
Dr. Anthony Jon Bock, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: York Hospital, 15 Hospital Drive, York, ME 03909 Phone: 207-351-2170 | |
Dr. Amy Wyatt, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 Hospital Dr, Emergency Department, York, ME 03909 Phone: 207-351-2170 Fax: 207-363-0120 | |
Dr. Sadie Carter, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Hospital Dr, York, ME 03909 Phone: 207-363-4321 Fax: 207-363-0120 | |
George Edward Hutchins Iii, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 Hospital Dr, York, ME 03909 Phone: 207-351-2170 Fax: 207-363-0120 | |
Dr. Nicholas C Armellino, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Hospital Dr, York, ME 03909 Phone: 207-263-4321 Fax: 207-363-0120 |